Background: Phthalates, a chemical class of plasticizers, are ubiquitous environmental contaminants that have been associated with oxidative stress. Mitochondria DNA copy number (mtDNAcn) and DNA deletions (mtDNAdel) are emerging biomarkers for cellular oxidative stress and environment exposures. Objectives: To examine associations of urinary phthalate metabolite and isoprostane concentrations on sperm mtDNAcn and mtDNAdel in male partners undergoing assisted reproductive technologies (ART). Methods: Ninety-nine sperm samples were collected from male partners undergoing ART at Baystate Medical Center in Springfield, MA as part of the Sperm Environmental Epigenetics and Development Study (SEEDS). Seventeen urinary phthalate metabolite concentrations were analyzed by the Centers for Disease Control using tandem mass spectrometry. Urinary 15-F2t-isoprostane concentrations, a biomarker of lipid peroxidation, were measured using a competitive enzyme-linked immunosorbent assay. A triplex qPCR method was used to determine the relative quantification of mtDNAcn and mtDNAdel. Results: Sperm mtDNAcn and mtDNAdel were positively correlated (Spearman rho = 0.31; p = .002). Adjusting for age, BMI, current smoking, race, and measurement batch, urinary monocarboxy-isononyl phthalate (MCNP) concentrations were positively associated with mtDNAcn (β = 1.63, 95% CI: 0.14, 3.11). Other urinary phthalate metabolite and isoprostane concentrations were not associated with sperm mtDNAcn or mtDNAdel. Conclusions: Among this cohort of male ART participants, those with higher MCNP had higher mtDNAcn; other phthalate metabolites and isoprostane were not associated with mtDNAcn and mtDNAdel. Given our relatively small sample size, our results should be interpreted with caution. Future research is needed to replicate the findings in larger studies and among sperm samples obtained from the general population.
Introduction
Phthalate diesters are a class of synthetic organic chemicals used in industrial and consumer products that include flexible vinyl plastics, medical equipment, food packaging, and personal care products (Johns et al., 2015; Zota et al., 2014) . Phthalate exposure is widespread, such that urinary phthalate metabolites have been detected in the majority of individuals from representative samples within the U.S. general population (CDC, 2010) . In humans, urinary phthalate metabolite concentrations have been associated with adverse male reproductive outcomes such as shorter anogenital distance (Suzuki et al., 2012; Swan et al., 2015) , abnormal sex steroid hormone synthesis (Meeker et al., 2009) , lower serum testosterone , reduced sperm motility, concentration (Cai et al., 2015; Pant et al., 2014) , and increased DNA damage (Hauser et al., 2007) . Additionally, studies of phthalate exposure animal models reported reduced sex organ weight (Shono and Taguchi, 2014) , abnormal Leydig cell aggregation (Mahood et al., 2007) , repression of sex determination , altered sex ratio (Dobrzynska et al., 2011) , and delayed sexual maturity (Lee et al., 2004) .
Oxidative stress, characterized by the disruption of redox signaling and control (Jones, 2006) , has been proposed a potential mediator in phthalate-associated adverse male reproductive outcome. Oxidative stress measures have been associated with diminished semen quality, including sperm motility, concentration, and morphology (Agarwal et al., 2014) . Isoprostanes, formed by the presence of free radicals and commonly used markers of lipid peroxidation in vivo (Kadiiska et al., 2005; Roberts and Morrow, 2002) , have been reported to be strongly associated with urinary phthalate metabolite concentrations among pregnant women (Ferguson et al., , 2015 Holland et al., 2016) as well as in our previous study among couples seeking fertility treatment (Wu et al., 2017c) . Similarly, a study of couples planning pregnancy reported that select urinary phthalate metabolite concentrations in both males and females were correlated with urinary 8-Oxo-2′-deoxyguanosine concentrations, a biomarker of oxidative stress via DNA oxidation (Guo et al., 2014) . It is currently unknown if phthalate exposure directly induces lipid peroxidation, or rather, it involves other intermediate biological targets that induce an imbalance in redox signaling.
Measures of the sperm mitochondrial genome may provide useful markers of oxidative stress, male fertility and environmental exposures. The mitochondrial genome is highly susceptible to oxidative damage due to its proximity to reactive oxygen species produced during oxidative phosphorylation and lack of protective defenses such as histones and DNA repair mechanisms (Phillips et al., 2014a; Sutovsky et al., 2003) . Mitochondria contain their own double-stranded 16.6 kb, circular, maternally-inherited genome that encodes 37 genes, which are involved in a host of biological functions including, most notably, ATP production and other homeostatic and signaling processes Phillips et al., 2014b) . The number of mitochondria vary widely across cell types and each mitochondrion can harbor between 1 and 10 copies of its genome (Phillips et al., 2014b; Robin and Wong, 1988) . Sperm mitochondrial copy number (mtDNAcn), the ratio of the number of mitochondrial genome copies to nuclear DNA (nDNA) copies, and percent of large deletions in the mitochondrial genome (mtDNAdel) have both been associated with oxidative stress measures (Abasalt et al., 2013; Bonanno et al., 2016) , and have also been associated with male infertility (Rajender et al., 2010) . In addition, leukocyte mtDNAcn and mtDNAdel have also been associated with markers of oxidative stress (Lee et al., 2000a; Liu et al., 2003a; Wang et al., 2011) , further supporting the sensitivity of mtDNAcn and mtDNAdel to oxidative stress and their potential use as biomarkers of this imbalance. One hypothesis suggests that increases in mtDNAcn may be a compensatory mechanism by which oxidative damage or mtDNAdel induce the propagation of the mitochondrial genome (Lee et al., 2000b) . Furthermore, one recent study reported that urinary polycyclic aromatic hydrocarbons (PAH) metabolite concentrations were inversely associated with sperm mtDNAcn among young Chinese men (Ling et al., 2017) , indicating the potential responsiveness of sperm mtDNAcn to environmental exposures as has been shown with leukocyte mtDNAcn and air pollution (Hou et al., 2010 (Hou et al., , 2013 Zhong et al., 2016) .
To further characterize the relation of phthalates with measures of male reproductive health and the role of oxidative stress, we examined the associations of urinary phthalate metabolite and isoprostane concentrations with mtDNAcn and mtDNAdel in sperm among couples seeking reproductive assistance.
Methods and materials

Study population
Couples were recruited as part of the Sperm Environmental Epigenetics and Development Study (SEEDS) from the Baystate Medical Center In Vitro Fertility (IVF) Program in Springfield, Massachusetts between 2014 and 2017. Inclusion criteria for male participants were 18-55 years of age without vasectomy, and for female participants were ≤ 40 years old. Furthermore, both males and females were required to use their own gametes to be eligible to participate in the study. Written consents from eligible males and females interested in participating were obtained by attending physicians. This study was approved by the institutional review boards at Baystate Medical Center and at the University of Massachusetts Amherst.
Covariate assessments
Relevant demographic (race, age, height, weight) and medical history data (diagnosis of infertility) were collected by clinic personnel during the course of an IVF cycle for both partners. In addition, each partner was asked to complete an intake questionnaire regarding lifestyle factors (current and past cigarette and alcohol use) prior to sample collection. Current smoking status was determined using a Cotinine ELISA kit (Calbiotech Cat#: CO096D) on a binary basis of smoker or non-smoker.
Urinary biomarker measurements
Phthalates
Men who agreed to participate provided a spot urine sample in a sterile polypropylene collection cup on the same day of semen sample procurement. Urine samples were vortexed, divided into several aliquots, and stored at −80°C. Urine samples were shipped overnight on dry ice to the National Center for Environmental Health of the Centers for Disease Control and Prevention (CDC), where quantification of urinary 1,2-Cyclohexane dicarboxylic acid diisononyl ester (DINCH) and phthalate metabolites was conducted via enzymatic deconjugation of the metabolites, solid-phase extraction, separation and detection using high performance liquid chromatography isotope dilution tandem mass spectrometry as described previously (Kato et al., 2005; Silva et al., 2013) . The following urinary phthalate and DINCH metabolites and Limits of detection (LOD) varied between batches and ranged from 0.1 to 0.9 ng/mL across all metabolites. Values falling under the LOD for each metabolite on each plate were replaced by the LOD/sqrt(2). Analytical standards, quality control (QC) materials prepared from spiked pooled urine, and reagent blank samples were included in each batch along with study samples. The QC concentrations, averaged to obtain one measurement of high-concentration QC and one of lowconcentration QC for each batch, were evaluated with standard statistical probability rules (Caudill et al., 2008) . The coefficient of variations for the phthalate measurement of QC materials ranged from 6.7% to 11.7% (low concentration standard) and 5.0-9.3% (high concentration standard).
Specific gravity was measured in urine by the CDC or by Baystate Reproductive Clinic using a handheld refractometer for participants (Atago Co., Ltd., Toko, Japan). The formula for dilution normalization of phthalate measurement by specific gravity is Pc = P[(SGm-1)/(SG-1)] where Pc is the SG-corrected metabolite concentration (ng/mL), P is the measured phthalate metabolite concentration, SGm is the median SG value of all samples, and SG is the specific gravity value for that individual urine sample. Values were log transformed for analyses.
Isoprostane
A competitive enzyme-linked immunoassay was used to measure urinary total 15-F2t isoprostane with pretreatment with β-glucuronidase as per the manufacturer's protocol (Cat#: EA84, Oxford Biomedical Research). (Wu et al., 2017c) . To increase the sample size used in our previous publication between phthalates and isoprostane (N = 50), we analyzed an additional 49 samples. Each plate was read twice on a SpectraMax M2 microplate reader (Molecular Devices). Samples were run in duplicate and those with coefficient of variations (CV) > 15% were repeated. Two control urines were used across all samples in this study (N = 99) to monitor batch effects. All values were corrected for urinary dilution using specific gravity as previously described above.
Sperm mitochondrial biomarker measurements
Semen samples were collected in a sterile plastic specimen cup after a recommended 2-3 day abstinence period, per standard IVF protocol. Motile sperm cells were isolated using a two-step gradient fractionation and DNA was isolated using our previously published protocol (Wu et al., 2015) .
To asses sperm mtDNAcn and mtDNAdel, we utilized the triplex design previously reported (Phillips et al., 2014b) to amplify mitochondria loci located within the MinorArc and MajorArc, respectively. To assess nDNA, we utilized RNase P Copy Number Reference Assay (ThermoFisher, cat# 4403326). A total of 10 ng of total sperm DNA was amplified with ProAmp Master Mix (ThermoFisher, cat#A30865) with final concentrations of 250 µM for MinorArc and MajorArc probes and primers and 1× concentration for RNAse P in a 10 µl PCR reaction on a StepOnePlus Real-Time PCR machine (ThermoFisher); the following conditions were used: 95°C for 10 min for activation, then 95°C for 15 s, 55°C for 15 s and 60°C for 60 s for 40 cycles. For each PCR reaction, mtDNAcn was determined via the following formula: 2^(meanΔCT), where ΔCT = (RNAse P CT-MinorArc CT). Similarly, mtDNAdel was calculated via: 2^(meanΔCT), where ΔCT = (MinorArc CT-MajorArc CT). All samples were run in triplicate.
A six-point standard curve was used to evaluate the linearity and amplification efficiency of the triplex reaction. All standard curves were R 2 > 0.999 and amplification efficiencies of 95.6%, 94.6% and 94.1%
for MajorArc, MinorArc and RNase P, respectively. Intra-assay CVs for MtDNAcn and MtDNAdel were 2.42% and 2.87%, and inter-assay CVs were 7.82% and 8.88%, respectively.
Statistical analyses
To examine the distributions of SG-corrected urinary phthalate metabolite and isoprostane concentrations, geometric means and selected percentiles were calculated. For bivariate analyses, we examined the correlation between the exposures, outcomes, and covariates using Spearman's correlation and Wilcoxon rank sum test, where appropriate. Generalized linear regression models (GLM) were used to examine the relationship of mtDNAcn and mtDNAdel with urinary phthalate metabolite and isoprostane concentrations. Covariates considered for inclusion were: age, body mass index (BMI), current smoking status (yes/ no), race (white/non-white), and measurement batches. Analyses were performed using R (R Core Team, Vienna, Austria). Covariates were chosen based on biological plausibility or those found to be associated with exposures or outcomes in bivariate analyses p-value < .1.
Results
Table 1 presents the demographic and fertility status for the current study population of men seeking fertility treatment. The average age and BMI was 36.1 ± 5.3 years old and 29.6 ± 6.0, respectively. The population was predominantly white (76%) and not current smokers (92%). Approximately 36% of individuals are classified as overweight ), while close to 38% of individuals could be classified as obese (BMI ≥ 30) . Approximately 27% of the population was diagnosed with male factor infertility.
The distributions of SG-corrected urinary phthalate metabolite and isoprostane concentrations (ng/mL) as well as sperm mtDNAcn (ratio of mtDNA copies per nuclear DNA copies) and mtDNAdel (percent of mtDNA deletions per total mtDNA copies) for male partners are shown in Table 2 . Twelve of the fifteen phthalate metabolites were measured above the LOD in more than 90% of samples (MEOHP, MEHHP, MECPP, MBzP, MBP, MHBP, MHiBP, MMP, MCOP, MEP, MCPP, and *BMI, body mass index was missing for n = 5.
Table 2
Distribution of specific gravity-adjusted urinary phthalate metabolite and isoprostane concentrations (ng/mL) and sperm mtDNAcn and mtDNAdel levels (n = 99).
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MCNP). Urinary phthalate concentrations in the current study are in line with those reported previously by our group (Wu et al., 2017b (Wu et al., , 2017c and others (CDC, 2010; Dodge et al., 2015) . Lower urinary concentrations were observed for the two metabolites of DINCH, a phthalate alternative, with 38% > LOD for MCOCH and 63.1% > LOD for MHINCH. The geometric mean (interquartile range (IQR)) for mtDNAcn and mtDNAdel were 1.99 (1.72) copies and 17.0% (14.7%). Additionally, mtDNAdel and mtDNAcn were found to be in significantly correlated (Spearman rho=0.31; p-value = .002). In bivariate analyses, BMI, current smoking status, and race were all associated with at least one urinary metabolite concentration, but none were associated with either MtDNAcn or MtDNAdel. Therefore, the multivariable models contained only age and measurement batch. Table 3 presents results from multivariable regression models for associations between mtDNAcn and urinary phthalate metabolite or isoprostane concentrations for the study population. Adjusting for age, BMI, current smoking status, race, and measurement batches, MCNP was positively associated with mtDNAcn (β = 1.323, 95% CI: 0.10, 2.55). No other statistically significant associations were found between mtDNAcn and urinary phthalate metabolite or isoprostane concentrations. Additional adjustment by BMI, current smoking, and race did not substantively impact the results. Table 4 presents results from multivariable regression models for associations between mtDNAdel and urinary phthalate metabolite or isoprostane concentrations for the study population. No statistically significant associations were found between mtDNAdel and urinary phthalate metabolite or isoprostane concentrations.
Discussion
In this study of male partners in the SEEDS cohort (n = 99), we observed a positive association between urinary concentrations of MCNP and mtDNAcn. Consistent with others (Ferguson et al., , 2015 Holland et al., 2016) and our previous study among a subset of male and female members of the SEEDS cohort (n = 50 couples), we observed urinary phthalate metabolite concentrations to be positively associated with biomarkers of oxidative stress among adults of reproductive age (Wu et al., 2017c) . Therefore, we hypothesized that sperm mtDNAcn and mtDNAdel would be positively associated with urinary phthalate metabolite and isoprostane concentrations. However, overall, sperm mtDNAcn and mtDNAdel were not associated with urinary concentrations of phthalate metabolites or isoprostane, a marker of lipid peroxidation in this study.
Environmental exposures
Emerging data indicate that mitochondrial biomarkers may be influenced by environmental exposures (Wallace, 2016) . For example, PAHs in indoor dust were inversely associated with leukocyte mtDNAcn (Pieters et al., 2013) . In contrast, coke-oven workers with occupational PAHs exposure displayed elevated lymphocytes mtDNAcn compared to controls (Pavanello et al., 2013) . Similarly, ambient particulate matter (PM) (Hou et al., 2010) , black carbon (Zhong et al., 2016) and occupational exposure to benzene (Carugno et al., 2012; Shen et al., 2008) were found to be positively associated with leukocyte mtDNAcn while elemental carbon levels were reported to be inversely related to leukocyte mtDNAcn (Hou et al., 2013) . Finally, prenatal PM exposure was reported to be inversely associated with placental mtDNAcn, while no associations were found between PM exposure and cord blood leukocyte mtDNAcn (Janssen et al., 2012) , suggesting cell-and tissue-specific differences between exposures and mitochondrial biomarkers likely exist.
To our knowledge only one study to date has examined associations between environmental exposures and sperm mtDNAcn and mtDNAdel. In a cross-sectional study of young Chinese men, four urinary PAH metabolites were reported to be inversely associated with sperm mtDNAcn; however, no associations were found between PAHs and mtDNAdel (Ling et al., 2017) . In our study, we observed a positive association between urinary MCNP and sperm mtDNAcn. The parent compound of MCNP, di-isodecyl phthalate (DIDP), is a high molecular weight phthalate used in food packaging and other consumer products as a replacement for DEHP; not surprisingly, diet is one of the major routes of human exposure to DIDP (Sakhi et al., 2014) . Potential pathways by which MCNP may influence sperm mtDNAcn are unknown. Fewer studies implicate MCNP with negative health outcomes than do other phthalate metabolites, however our results suggest further investigation is warranted. Among pregnant women, urinary MCNP was inversely associated with free testosterone (Sathyanarayana et al., 2017) , suggesting an anti-androgenic effect of MCNP. In mice, oral DIDP exposure was recently shown to increase ROS and decrease glutathione levels (Shen et al., 2017) , suggesting a DIDP-dependent Table 3 Adjusted effect estimates (95% CI) for urinary phthalate metabolite and isoprostane concentrations and mtDNAcn levels. increase in oxidative stress. However, we have previously reported that other phthalate metabolites, but not MCNP, were associated with urinary isoprostane in men (N =50) from SEEDS (Wu et al., 2017c) and in current study with a larger samples size (data not shown). Thus, our data do not support a role for isoprostane as a potential mediator in the association observed between MCNP and mtDNAcn, although we cannot rule out the possibility of the involvement of other oxidative stress pathways. Our previous findings in SEEDS have shown that anti-androgenic phthalate metabolites were associated with sperm DNA methylation and diminished embryo quality (Wu et al., 2017a ). In the current study we observed null findings between phthalates and mitochondrial biomarkers, which may be due in part to the tight regulation of sperm mitochondria during spermatogenesis, a 74 day process in humans in which male germ cells undergo extensive reprogramming events to progress from diploid spermatogonia to haploid spermatozoa. In addition to the morphological and epigenetic changes that occur during spermatogenesis, key regulators of the mitochondrial genome are down-regulated resulting in a depletion of mitochondria and mtDNAcn in mature sperm that largely occurs during the transition from round to elongated spermatid (Rajender et al., 2010) . Approximately 22-80 mitochondria are found in mature mammalian sperm -a tenth of its original number (Bahr and Engler, 1970; St John et al., 2000) and form a tight helix around the midpiece to provide the necessary energy for motility via flagellar propulsion (Rajender et al., 2010) . The active depletion of sperm mitochondria underlies the maternal inheritance of mtDNA (Song et al., 2014) and has also been proposed as a mechanism that protects mature sperm against ROS-mediated damage to sperm membrane and DNA (Tremellen, 2008) . Indeed, higher sperm mtDNAcn has been associated with male infertility and poor semen parameters (Gabriel et al., 2012; Kao et al., 2004; May-Panloup et al., 2003; Zhang et al., 2016) . Thus, a precise balance of mitochondria is essential to meet the energetic demands of motile sperm while safeguarding against oxidative damage; our overall data suggest that phthalate exposure may not affect this balance. Alternatively, it should be noted that sperm used in our study were obtained after gradient centrifugation, a process that removes abnormal sperm and concentrates the motile fraction representing those sperm with high fertilization capacity. Therefore, we cannot rule out the possibility that phthalates may influence mitochondrial biomarkers in unprocessed semen from the general population. Additionally, our study was limited to a single spot urine sample on the day of semen collection; thus, we recognize that the short halflife of phthalates may pose a concern for accurate exposure assessment; however, several reports indicate that a single spot urine sample sufficiently represents phthalate exposure over several months (Hauser et al., 2004; Hoppin et al., 2004; Teitelbaum et al., 2008) .
Oxidative stress
Previous studies have shown that indices of oxidative stress are positively associated with mtDNAcn in both sperm (Abasalt et al., 2013; Bonanno et al., 2016) and somatic cells (Lee et al., 2000a; Liu et al., 2003b; Wang et al., 2011) . Our overall results found no association between urinary isoprostane and sperm mtDNAcn and mtDNAdels. The lack associations observed between urinary isoprostane and sperm mitochondrial biomarkers in our study is unknown but may be reflective of our biomarker used to assess lipid peroxidation. F2-isoprostane is considered to be a gold standard of systemic oxidative stress in epidemiologic studies (Yin et al., 2005) ; however, due to the relatively short half-life of isoprostane, a single spot urine sample represents oxidative stress levels within a 24-h period (Basu and Helmersson, 2005) . Thus, urinary isoprostane concentrations in our study may not accurately reflect the state of oxidative stress during the critical window (e.g., transition from round to elongated spermatids) when mitochondria and mtDNAcn are depleted. Such temporal issues have been proposed to also explain the lack of association between plasma isoprostane and mtDNAcn in leukocytes (Lakkur et al., 2014) . Lastly, we also have to acknowledge that isoprostane is an indicator of systemic marker of oxidative stress and may not reflect localized lipid peroxidation such as 4-hydroxynonenal and malondialdehyde, commonly found in sperm (Moazamian et al., 2015) .
Conclusions
To our knowledge, this is the first study to investigate the relationship of sperm mtDNAcn and mtDNAdel with urinary phthalate metabolite and lipid peroxidation concentrations. Our results from 99 men of couples seeking fertility treatment show that mtDNAcn is associated with MCNP, mtDNAdel is not associated with any phthalate metabolites, and isoprostane is not associated with either mtDNAcn or mtDNAdel. Given our relatively small sample size, our results should be interpreted with caution. Additional studies are necessary to examine these associations in larger studies of men recruited from fertility clinics as well as the general population.
